Lyra Therapeutics Inc. (LYRA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Perceptive Advisors

Joseph Edelman

255,151.24 $1,607,453 0.06%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

27,802.6 $175,573 -30% 0.03%
3.
Ikarian Capital

Neil Shahrestani

21,162.96 $133,645 0.02%
4.
ADAR1 Capital Management

Daniel Schneeberger

10,664 $67,343 0.01%
5.
Two Sigma Advisors

John Overdeck And David Siegel

7,289.56 $46,034 -6% 0%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$2.96 25,000 $74,095.00 261,966 2023-11-10 Filing
$2.43 1,203,612 $2,924,777.16 2,521,745 2023-05-31 Filing
$2.43 197,946 $481,008.78 1,107,370 2023-05-31 Filing
$2.43 403,858 $981,374.94 2,259,301 2023-05-31 Filing
$2.43 1,203,612 $2,924,777.16 2,521,745 2023-05-31 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$16.00 16,909 $270,544.00 457,421 2020-05-05 Filing
$16.00 7,255 $116,080.00 478,123 2020-05-05 Filing
$16.00 5,568 $89,088.00 324,057 2020-05-05 Filing
$16.00 11,360 $181,760.00 661,153 2020-05-05 Filing
$16.00 7,255 $116,080.00 478,123 2020-05-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 60,379.72 $381,298 0%
2. 35,311.7 $222,464 0%
3. 20,320.08 $128,338 0%
4. 9,774.4 $61,725 0%
5. 8,684.52 $54,712 0%
News See All